Richard Naiberg at CBA and OBA Update on the Biosimilar Landscape in Canada
|Area||Litigation, Intellectual Property|
Twenty Toronto Street Conferences and Events
20 Toronto Street, 2nd Floor, Toronto
Friday, October 14, 2016
10:35 am Update on Biosimilar Litigation
Speaker: Richard Naiberg, Partner, Goodmans LLP
This session will include the following topics:
This panel provided an update on:
- Litigation experiences with SEBs and biologics
- SEB litigation versus small molecules – is there any difference?
- Current and future challenges for regulatory agencies in Canada and abroad
For more information, please click here.